Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program

Go back to Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
(NASDAQ: DTIL) Delayed: 7.29 +0.54 (8.00%)
Previous Close $6.75    52 Week High
Open $6.73    52 Week Low
Day High $7.60    P/E N/A 
Day Low $6.73    EPS
Volume 3,340,822